TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 54.8M
Total Liabilities 46.7M
Shareholders Equity 8.0M
Debt to Equity 5.81

Cash Flow Metrics

Revenue & Profitability Trend

Medirom Healthcare Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i56.2M46.2M47.1M5.4B3.3B
Cost of Goods Sold i41.0M35.6M34.2M4.0B2.9B
Gross Profit i15.2M10.6M12.9M1.4B429.0M
Gross Margin % i27.1%23.0%27.4%26.2%12.8%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i15.2M13.3M12.2M1.8B1.1B
Other Operating Expenses i-93.8K-144.8K-139.7K-27.8M-111.6M
Total Operating Expenses i15.1M13.1M12.1M1.8B957.0M
Operating Income i126.1K-2.5M796.4K-379.5M-528.0M
Operating Margin % i0.2%-5.4%1.7%-7.0%-15.8%
Non-Operating Items
Interest Income i547.5K41.1K839.0K1.3M
Interest Expense i336.9K249.7K66.4K12.0M13.2M
Other Non-Operating Income533.9K2.9M446.4K-23.8M-86.8M
Pre-tax Income i323.1K139.7K1.2M-414.5M-626.7M
Income Tax i-612.8K-639.5K208.7K576.2M-87.5M
Effective Tax Rate % i-189.6%-457.9%17.1%0.0%0.0%
Net Income i935.9K779.2K1.0M-990.7M-539.2M
Net Margin % i1.7%1.7%2.1%-18.3%-16.1%
Key Metrics
EBITDA i2.4M-883.3K2.4M-228.1M-444.7M
EPS (Basic) i-$23.64$30.54$-203.13$-223.88
EPS (Diluted) i-$22.34$27.23$-203.13$-223.88
Basic Shares Outstanding i-3306733033706823777698867055
Diluted Shares Outstanding i-3306733033706823777698867055

Income Statement Trend

Medirom Healthcare Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i2.2M720.3K4.1M370.6M1.4B
Short-term Investments i41.7K179.5K179.5K26.5M32.5M
Accounts Receivable i9.2M4.2M3.6M312.3M148.5M
Inventory i1.0M948.1K772.8K18.7M8.0M
Other Current Assets1.5M1.7M2.0M111.2M-
Total Current Assets i18.3M11.9M16.0M1.4B2.1B
Non-Current Assets
Property, Plant & Equipment i14.0M14.2M13.2M1.8B1.6B
Goodwill i13.0M12.8M10.0M1.6B399.1M
Intangible Assets i7.7M6.2M2.7M391.0M97.6M
Long-term Investments-----
Other Non-Current Assets3.1M1.4M765.1K209.1M852.0M
Total Non-Current Assets i36.5M34.5M29.7M4.4B3.6B
Total Assets i54.8M46.4M45.7M5.8B5.7B
Liabilities
Current Liabilities
Accounts Payable i6.9M932.6K1.4M230.9M67.0M
Short-term Debt i12.9M8.6M5.9M917.5M900.6M
Current Portion of Long-term Debt-----
Other Current Liabilities2.8M2.5M3.6M418.8M118.9M
Total Current Liabilities i28.3M24.1M24.7M3.2B2.7B
Non-Current Liabilities
Long-term Debt i13.9M16.2M16.0M1.9B1.7B
Deferred Tax Liabilities i-----
Other Non-Current Liabilities1.7M1.8M2.3M354.1M383.2M
Total Non-Current Liabilities i18.4M20.8M21.4M2.8B2.6B
Total Liabilities i46.7M44.9M46.1M6.0B5.2B
Equity
Common Stock i2.4M135.5K8.3M1.2B1.2B
Retained Earnings i1.6M543.7K-17.2M-2.7B-1.7B
Treasury Stock i20.3K20.3K20.3K3.0M3.0M
Other Equity-----
Total Shareholders Equity i8.0M1.5M-402.1K-208.3M491.3M
Key Metrics
Total Debt i26.8M24.7M21.9M2.8B2.6B
Working Capital i-10.0M-12.2M-8.7M-1.8B-565.4M

Balance Sheet Composition

Medirom Healthcare Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i935.9K779.2K1.0M-990.7M-539.2M
Depreciation & Amortization i2.0M1.7M1.2M126.2M62.3M
Stock-Based Compensation i-00196.9M0
Working Capital Changes i6.7M1.8M-3.0M-45.9M-107.1M
Operating Cash Flow i8.7M3.9M-728.2K-161.3M-689.4M
Investing Activities
Capital Expenditures i-483.6K-920.0K-542.6K-95.7M-70.3M
Acquisitions i6.0M4.0M4.8M54.2M-99.2M
Investment Purchases i-38.3K-21.0K0-78.9M-26.7M
Investment Sales i200.2K006.0M63.0M
Investing Cash Flow i5.8M3.1M4.2M-65.8M-109.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i2.0M03.7M0775.0M
Debt Repayment i-4.6M-671.1K-1.4M-251.1M-386.4M
Financing Cash Flow i4.1M3.1M1.2M-515.6M1.2B
Free Cash Flow i-12.8M-10.5M-5.8M-671.0M-470.5M
Net Change in Cash i18.6M10.1M4.7M-742.7M447.0M

Cash Flow Trend

Medirom Healthcare Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 9.47
Price to Book 0.02
Price to Sales 0.00

Profitability Ratios

Profit Margin 1.79%
Operating Margin 13.30%
Return on Equity 22.96%
Return on Assets 0.04%

Financial Health

Current Ratio 0.65
Debt to Equity 400.54
Beta 0.88

Per Share Data

EPS (TTM) $0.19
Book Value per Share $118.11
Revenue per Share $1,624.92

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
mrm14.2M9.470.0222.96%1.79%400.54
Rollins 28.1B57.3719.4536.52%13.71%66.99
Service 11.3B21.946.8932.72%12.58%292.19
Medifast 155.5M42.880.671.73%0.76%6.05
Yy Group Holding 75.9M20.2311.12-93.74%-11.77%81.32
Regis 47.7M0.520.69548.07%49.34%535.95

Financial data is updated regularly. All figures are in the company's reporting currency.